AngelEye Well being Acquires EDNA Portfolio to Enhance Neonatal Care
AngelEye Well being, a supplier of neonatal and pediatric household engagement companies, has agreed to accumulate Enlighten Mobility’s Early Detection Neuromotor Assessments (EDNA) portfolio.
The monetary phrases and different particulars of the transaction stay unknown.
This strategic transfer goals to develop AngelEye’s capabilities in deploying bedside sensors for early intervention in neonatal care.
The mixing of the EDNA platform into AngelEye, which is utilized in almost 250 hospitals and over 7,000 beds, is predicted to have a big influence on the neonatal intensive care unit (NICU).
The EDNA platform makes use of movement evaluation, scientific experience, sensors and synthetic intelligence to determine danger components in newborns, resembling neuromotor issues, positioning or sepsis.
These dangers can usually result in longer hospital stays and long-term well being issues.
Entry probably the most complete firm profiles available on the market, powered by GlobalData. Save hours of analysis. Achieve a aggressive edge.
Firm Profile – Free Pattern
Your obtain e-mail will arrive shortly
We’re satisfied of the distinctive high quality of our firm profiles. Nevertheless, we wish you to take advantage of useful determination in your firm, so we provide a free pattern you could obtain by submitting the shape under
By GlobalData
EDNA's sensor-based platform gives clinicians with crucial data to extra successfully assist infants and their households early on, bettering outcomes.
EDNA's algorithms and scientific service mannequin have been developed in collaboration with high scientists and hospitals, together with Nationwide Youngsters's Hospital.
Based on AngelEye, analysis is ongoing to validate and uncover further sensor-based algorithms and companies for newborns.
Christopher Rand, CEO of AngelEye Well being, stated: “The acquisition of the EDNA portfolio is a pivotal second for AngelEye.
“Combining our industry-leading footprint with EDNA’s portfolio offers us the chance to increase our attain past engagement and into the realm of supportive scientific care.
“This strategic transaction permits us to leverage our established relationships and infrastructure within the NICU to offer clinicians with a better means to determine at-risk sufferers and assist their care pathway within the NICU and past.”
The most recent acquisition marks a big step for AngelEye Well being in its mission to enhance neonatal care, increasing the scope of its companies from household engagement to direct scientific assist.
Since its founding in 2013, AngelEye has maintained a excessive retention fee of over 98% and has partnered with hospitals within the US, EU, Canada and Australia.
